According to our (Global Info Research) latest study, the global Digital Therapy for Diabetes market size was valued at US$ 2914 million in 2025 and is forecast to a readjusted size of US$ 8077 million by 2032 with a CAGR of 15.6% during review period.
Digital diabetes therapy refers to digital treatment solutions that utilize clinically validated software programs, artificial intelligence algorithms, mobile applications, cloud computing platforms, wearable devices, and digital health technologies to provide diabetes patients with digital treatment options including prevention, risk assessment, blood glucose management, behavioral intervention, lifestyle improvement, and disease treatment support. These products typically leverage multidimensional health data such as blood glucose levels, diet, exercise, sleep, and medication adherence to achieve long-term management of patients with type 2 diabetes, type 1 diabetes, and prediabetes through personalized feedback, intelligent reminders, remote monitoring, cognitive behavioral intervention (CBT), nutritional management, and AI predictive models. Unlike ordinary health management apps, digital therapy emphasizes evidence-based medicine validation, clinical effectiveness, and treatment goals. Some products can be used as medical intervention tools in conjunction with drug therapy, insulin therapy, and continuous glucose monitoring (CGM) systems.
The future of digital diabetes therapy is promising and transformative. By integrating artificial intelligence, wearable devices, and continuous glucose monitoring technology, it is driving a shift in diabetes management from the traditional "passive treatment" to a closed-loop model of "active intervention," enabling personalized, data-driven management from high-risk screening to complication prevention. Evidence-based medicine has already demonstrated that such interventions can effectively reduce patients' dependence on medication and even help some type 2 diabetes patients achieve long-term stable blood glucose levels after discontinuing medication. With the improvement of regulatory frameworks, the establishment of payment systems, and deep integration with clinical workflows, digital therapy is expected to become a core force in reshaping chronic disease management pathways, allowing precision medicine to truly benefit every patient.
Report Scope
This report is a detailed and comprehensive analysis for global Digital Therapy for Diabetes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Digital Therapy for Diabetes market size and forecasts, in consumption value ($ Million), 2021-2032
Global Digital Therapy for Diabetes market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Digital Therapy for Diabetes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Digital Therapy for Diabetes market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Digital Therapy for Diabetes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Digital Therapy for Diabetes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Welldoc, DarioHealth, Omada Health, Better Therapeutics, Click Therapeutics, Hedia, Sweetch Health, Wellthy Therapeutics, Health2Sync, Fitterfly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Digital Therapy for Diabetes market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Type
Blood Glucose Control-Focused
Lifestyle Intervention-Focused
Medication-Assisted
Complication Prevention-Focused
Comprehensive Chronic Disease Management-Focused
Market segment by Business Models
B2B Model
B2C Model
B2B2C Model
Market segment by Application
Digital Therapeutics for Type 2 Diabetes
Digital Therapeutics for Type 1 Diabetes
Digital Therapeutics for Prediabetes
Market segment by players, this report covers
Welldoc
DarioHealth
Omada Health
Better Therapeutics
Click Therapeutics
Hedia
Sweetch Health
Wellthy Therapeutics
Health2Sync
Fitterfly
Oviva
Liva Healthcare
Yidu Tech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Digital Therapy for Diabetes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Digital Therapy for Diabetes, with revenue, gross margin, and global market share of Digital Therapy for Diabetes from 2021 to 2026.
Chapter 3, the Digital Therapy for Diabetes competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Digital Therapy for Diabetes market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Therapy for Diabetes.
Chapter 13, to describe Digital Therapy for Diabetes research findings and conclusion.
Summary:
Get latest Market Research Reports on Digital Therapy for Diabetes. Industry analysis & Market Report on Digital Therapy for Diabetes is a syndicated market report, published as Global Digital Therapy for Diabetes Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Digital Therapy for Diabetes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.